EPISODE · Apr 8, 2026 · 2 MIN
US Tariffs Hit Indian Steel, Aluminum, and Pharma Exports Hard in April 2025 Changes
from India Tariff News and Tracker · host Inception Point AI
Welcome to India Tariff News and Tracker, where we break down the latest US tariff developments impacting Indian exporters and businesses. Listeners, as President Trump's aggressive trade agenda rolls on, India faces mounting pressure from escalating US duties, with no specific carve-outs yet for New Delhi amid ongoing bilateral talks. Parker Poe reports that on April 7, the US Court of International Trade broadened relief from IEEPA tariffs—imposed starting February 2025—allowing refunds even on finalized liquidations, a win for importers as CBP's CAPE system gears up for mid-April rollout, potentially covering 63% of entries in phase one. But for Indian steel, aluminum, and pharma shipments, this doesn't erase the duties upfront. JD Supra details a seismic April 2 proclamation revising Section 232 tariffs on steel, aluminum, and copper, effective April 6. Annex I-A goods now face 50% duties on full customs value—up from metal-content only—with no stacking for derivatives. Indian exports, lacking US or UK melt/pour exemptions, hit the full 50% or 25% rates per annex, plus a new 15% de minimis waiver for items under 15% metal weight. Thompson Hinesmartrade confirms Trump's move strengthens US industries but squeezes global suppliers like India, whose steel and aluminum face no relief. Pharma exporters, take note: Bird & Bird and STR Trade reveal April 2 Section 232 tariffs slamming patented drugs and APIs at 100% from July 31 or September 29, 2026. India, a generics powerhouse, dodges this—exempted alongside biosimilars—but APIs could snag if patented. Allies like Japan get 15% cuts; India watches from the sidelines. Joint Economic Committee warns Trump's copper and steel tariffs spiked US prices 25% and 21% by February, curbing housing builds and jobs—ripples that could slow Indian metal demand. Stay vigilant, listeners: With Commerce and USTR eyeing more tweaks by July 1, Indian firms should probe onshoring or drawback options now. Thank you for tuning in to India Tariff News and Tracker—subscribe for weekly updates. This has been a Quiet Please production, for more check out quietplease.ai. For more check out https://www.quietperiodplease.com/ Avoid ths tariff fee's and check out these deals https://amzn.to/4iaM94Q This content was created in partnership and with the help of Artificial Intelligence AI.
What this episode covers
Welcome to India Tariff News and Tracker, where we break down the latest US tariff developments impacting Indian exporters and businesses. Listeners, as President Trump's aggressive trade agenda rolls on, India faces mounting pressure from escalating US duties, with no specific carve-outs yet for New Delhi amid ongoing bilateral talks. Parker Poe reports that on April 7, the US Court of International Trade broadened relief from IEEPA tariffs—imposed starting February 2025—allowing refunds even on finalized liquidations, a win for importers as CBP's CAPE system gears up for mid-April rollout, potentially covering 63% of entries in phase one. But for Indian steel, aluminum, and pharma shipments, this doesn't erase the duties upfront. JD Supra details a seismic April 2 proclamation revising Section 232 tariffs on steel, aluminum, and copper, effective April 6. Annex I-A goods now face 50% duties on full customs value—up from metal-content only—with no stacking for derivatives. Indian exports, lacking US or UK melt/pour exemptions, hit the full 50% or 25% rates per annex, plus a new 15% de minimis waiver for items under 15% metal weight. Thompson Hinesmartrade confirms Trump's move strengthens US industries but squeezes global suppliers like India, whose steel and aluminum face no relief. Pharma exporters, take note: Bird & Bird and STR Trade reveal April 2 Section 232 tariffs slamming patented drugs and APIs at 100% from July 31 or September 29, 2026. India, a generics powerhouse, dodges this—exempted alongside biosimilars—but APIs could snag if patented. Allies like Japan get 15% cuts; India watches from the sidelines. Joint Economic Committee warns Trump's copper and steel tariffs spiked US prices 25% and 21% by February, curbing housing builds and jobs—ripples that could slow Indian metal demand. Stay vigilant, listeners: With Commerce and USTR eyeing more tweaks by July 1, Indian firms should probe onshoring or drawback options now. Thank you for tuning in to India Tariff News and Tracker—subscribe for weekly updates. This has been a Quiet Please production, for more check out quietplease.ai. For more check out https://www.quietperiodplease.com/ Avoid ths tariff fee's and check out these deals https://amzn.to/4iaM94Q This content was created in partnership and with the help of Artificial Intelligence AI.
NOW PLAYING
US Tariffs Hit Indian Steel, Aluminum, and Pharma Exports Hard in April 2025 Changes
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.